Ticagrelor
- Product NDC
- 72516-017
- 11-digit product format
- 725160017
- Labeler code
- 72516
- Product ID
- 72516-017_461d8570-9132-90a2-e063-6294a90abb5a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ticagrelor
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Oryza Pharmaceuticals, Inc.
- Application
- ANDA208508
- Marketing category
- ANDA
- Marketing start
- 2025-12-01
- Substance
- TICAGRELOR
- Active strength
- 60 mg/1
- Pharmacologic classes
- Cytochrome P450 3A4 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P-Glycoprotein Inhibitors [MoA], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ticagrelor
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TICAGRELOR | 60 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | GLH0314RVC |
| Rxcui | 1666332 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72516-017-06 | Ticagrelor | 60 in 1 BOTTLE | TABLET | 60 | | 1 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72516-017-06 | 72516001706 | 60 TABLET in 1 BOTTLE (72516-017-06) | 60 tablet | 2025-12-01 | No | No | Historical |